SCHEMBL19196152

SCHEMBL19196152

COC(=O)c1ccc(C(=O)OC2CCC(C)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 2/20 0.50
SCN2A Q99250 2/20 0.50
SCN3A Q9NY46 2/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48
MAPT P10636 4/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9002108 0.93 SCN1A (0.56) SCN1ASCN2ASCN3ANPC1RAB9A
SCHEMBL21185763 0.87 SMN1; SMN2 (0.52) SCN1ASCN2ASCN3ANPC1RAB9A
SCHEMBL13038152 0.86 SCN1A (0.67) SCN1ASCN2ASCN3ATDP1NPC1
SCHEMBL29446093 0.86 SMN1; SMN2 (0.61) SCN1ASCN2ASCN3ACA1CA2
SCHEMBL21820632 0.85 LMNA (0.58) SCN1ASCN2ASCN3ANPC1RAB9A
SCHEMBL21820633 0.85 LMNA (0.58) SCN1ASCN2ASCN3ANPC1RAB9A
SCHEMBL8367136 0.84 MEN1 (0.64) SCN1ASCN2ASCN3ATDP1MAPT
SCHEMBL3468810 0.84 SMN1; SMN2 (0.64) SCN1ASCN2ASCN3ANPC1RAB9A
SCHEMBL21426604 0.83 SCN1A (0.48) SCN1ASCN2ASCN3ATDP1NPC1
SCHEMBL19431401 0.83 SMN1; SMN2 (0.48) SCN1ASCN2ASCN3ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023073644-A1 ENCAPSULATION OF FLAME RETARDANT AGENTS BY ATOMIC LAYER DEPOSITION FOR IMPROVED FLAME RETARDANT FORMULATIONS SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2023-05-04 WO disclosed
EP-4174124-A1 ENCAPSULATION OF FLAME RETARDANT AGENTS BY ATOMIC LAYER DEPOSITION FOR IMPROVED FLAME RETARDANT FORMULATIONS SHPP Global Technologies B.V. (NL) 2023-05-03 EP disclosed
US-20180208711-A1 METHODS OF FORMING DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-07-26 US disclosed
US-20180201777-A1 FIBRILLATED DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS AND METHODS OF THEIR MANFUACTURE AND USE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-07-19 US disclosed
US-20180118899-A1 FIBRILLATED DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS AND METHODS OF THEIR MANUFACTURE AND USE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-05-03 US disclosed
US-20180118875-A1 USE OF DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS IN SOLDERING APPLICATIONS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-05-03 US disclosed
US-20170218192-A1 METHODS OF FORMING DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118899-A1 FIBRILLATED DYNAMIC CROSS-LINKED POLYMER COMPOSITIONS AND METHODS OF THEIR MANUFACTURE AND USE MFAP1, PFN1, FSCN1 SCN1A 3013/4885SCN2A 2936/4885SCN3A 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.